Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Graves' Dysthyroid Ophthalmopathy
NCT00424151Phase 2Completed
- Start
- Dec 2006
- Primary completion
- Mar 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in thyroid eye disease (TED). Started Dec 2006; status: completed.
02
Drugs
rituximab
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT00424151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424151.